Barbara Incerti
Vita-Salute San Raffaele University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Barbara Incerti.
American Journal of Human Genetics | 2000
Maria Pia Sperandeo; Maria Teresa Bassi; Mirko Riboni; Giancarlo Parenti; Anna Buoninconti; Marta Manzoni; Barbara Incerti; Maria Rosaria Larocca; Maja Di Rocco; Pietro Strisciuglio; Irma Dianzani; Rossella Parini; Miranda Candito; Fumio Endo; Andrea Ballabio; Generoso Andria; Gianfranco Sebastio; Giuseppe Borsani
Lysinuric protein intolerance (LPI) is a rare autosomal recessive defect of cationic amino acid transport caused by mutations in the SLC7A7 gene. We report the genomic structure of the gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. The SLC7A7 gene consists of 10 exons; sequences of all of the exon-intron boundaries are reported here. All of the mutant alleles were characterized and eight novel mutations were detected, including two missense mutations, 242A-->C (M1L) and 1399C-->A (S386R); a nonsense mutation 967G-->A (W242X); two splice mutations IVS3 +1G-->A and IVS6 +1G-->T; a single-base insertion, 786insT; and two 4-bp deletions, 455delCTCT and 1425delTTCT. In addition, a previously reported mutation, 1625insATCA, was found in one patient. It is noteworthy that 242A-->C causes the change of Met1 to Leu, a rare mutational event previously found in a few inherited conditions. We failed to establish a genotype/phenotype correlation. In fact, both intrafamilial and interfamilial phenotypic variability were observed in homozygotes for the same mutation. The DNA-based tests are now easily accessible for molecular diagnosis, genetic counseling, and prenatal diagnosis of LPI.
Human Molecular Genetics | 2008
Ilaria Palmisano; Paola Bagnato; Angela Palmigiano; Giulio Innamorati; Giuseppe Rotondo; Domenico Altimare; Consuelo Venturi; Elena V. Sviderskaya; Rosanna Piccirillo; Massimiliano Coppola; Valeria Marigo; Barbara Incerti; Andrea Ballabio; Enrico Maria Surace; Carlo Tacchetti; Dorothy C. Bennett; Maria Vittoria Schiaffino
The protein product of the ocular albinism type 1 gene, named OA1, is a pigment cell-specific G protein-coupled receptor exclusively localized to intracellular organelles, namely lysosomes and melanosomes. Loss of OA1 function leads to the formation of macromelanosomes, suggesting that this receptor is implicated in organelle biogenesis, however the mechanism involved in the pathogenesis of the disease remains obscure. We report here the identification of an unexpected abnormality in melanosome distribution both in retinal pigment epithelium (RPE) and skin melanocytes of Oa1-knock-out (KO) mice, consisting in a displacement of the organelles from the central cytoplasm towards the cell periphery. Despite their depletion from the microtubule (MT)-enriched perinuclear region, Oa1-KO melanosomes were able to aggregate at the centrosome upon disruption of the actin cytoskeleton or expression of a dominant-negative construct of myosin Va. Consistently, quantification of organelle transport in living cells revealed that Oa1-KO melanosomes displayed a severe reduction in MT-based motility; however, this defect was rescued to normal following inhibition of actin-dependent capture at the cell periphery. Together, these data point to a defective regulation of organelle transport in the absence of OA1 and imply that the cytoskeleton might represent a downstream effector of this receptor. Furthermore, our results enlighten a novel function for OA1 in pigment cells and suggest that ocular albinism type 1 might result from a different pathogenetic mechanism than previously thought, based on an organelle-autonomous signalling pathway implicated in the regulation of both membrane traffic and transport.
The New England Journal of Medicine | 2010
David Bick; Brunella Franco; Richard J. Sherins; Babette Heye; Lisa Pike; John D. Crawford; Anne Maddalena; Barbara Incerti; Antonella Pragliola; Thomas Meitinger; Andrea Ballabio
The New England Journal of Medicine | 1992
David Bick; Brunella Franco; Richard J. Sherins; Babette Heye; Lisa Pike; John D. Crawford; Anne Maddalena; Barbara Incerti; Antonella Pragliola; Thomas Meitinger; Andrea Ballabio
Human Molecular Genetics | 2000
Barbara Incerti; Katia Cortese; Alessandro Pizzigoni; Enrico Maria Surace; Simona Varani; Massimiliano Coppola; Glen Jeffery; Mathias W. Seeliger; Gesine B. Jaissle; Dorothy C. Bennett; Valeria Marigo; Maria Vittoria Schiaffino; Carlo Tacchetti; Andrea Ballabio
Human Molecular Genetics | 2000
Marilena d’Addio; Alessandro Pizzigoni; Maria Teresa Bassi; Cinzia Baschirotto; Caterina Valetti; Barbara Incerti; Maurizio Clementi; Michele De Luca; Andrea Ballabio; Maria Vittoria Schiaffino
Genomics | 1998
Maria Pia Sperandeo; Giuseppe Borsani; Barbara Incerti; Massimo Zollo; Elena Rossi; Orsetta Zuffardi; Pasqualina Castaldo; Maurizio Taglialatela; Generoso Andria; Gianfranco Sebastio
The Journal of Pediatrics | 1995
Giancarlo Parenti; Gianfranco Sebastio; Pietro Strisciuglio; Barbara Incerti; Carmine Pecoraro; Luigi Maria Terracciano; Generoso Andria
American Journal of Medical Genetics | 1995
Giancarlo Parenti; Maria Grazia Rizzolo; Monica Ghezzi; Salvatore Di Maio; Maria Pia Sperandeo; Barbara Incerti; Brunella Franco; Andrea Ballabio; Generoso Andria
Genomics | 1998
Pasquale Buanne; Barbara Incerti; Daniele Guardavaccaro; Virginia Avvantaggiato; Antonio Simeone; Felice Tirone